Subscribe To
Investor alert: abbott cooper pllc announces investigation into zentalis pharmaceuticals, inc.; urges zentalis stockholders to contact abbott cooper regarding their legal rights
STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” ...
November 4, 2023, 3:53 pm
Former crypto day traders say no thanks even as bitcoin roars back
(Bloomberg) — Between 2013 and 2017, Peter To claims he made more than $1 million by day-trading Bitcoin during its bull runs. Most Read from Bloomb...
November 4, 2023, 2:29 pm
Weaker than expected nz labour market data drives weaker nzd and rates
US Fed leaves rates on hold for a second consecutive meeting. US Treasury’s quarterly refunding announce...
November 4, 2023, 10:59 am
Clip: t-bills remain the best game in town
The Q4 refunding announcement has relieved rate pressure across the Treasury curve. Yet, debt levels an...
November 4, 2023, 10:28 am
Sedg investor alert: robbins geller rudman & dowd llp announces that solaredge technologies, inc. investors with substantial losses have opportunity to lead the solaredge class action lawsuit
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchaser...
November 4, 2023, 2:55 am
Otlk investor alert: robbins geller rudman & dowd llp announces that outlook therapeutics, inc. investors with substantial losses have opportunity to lead the outlook therapeutics class action lawsuit
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the Outlo...
November 4, 2023, 12:13 am
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Correction – the herzfeld caribbean basin fund, inc. announces estimated subscription price for rights offering
MIAMI BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by The Herzfeld Caribbean Basin Fund (...
November 3, 2023, 10:15 pm
Lgi homes, inc. reports october 2023 home closings
THE WOODLANDS, Texas, Nov. 03, 2023 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced...
November 3, 2023, 9:05 pm
Mobiv acquisition corp provides further update on planned business combination
Newark, DE, Nov. 03, 2023 (GLOBE NEWSWIRE) — Mobiv Acquisition Corp (the “Company” or “Mobiv”) annou...
November 3, 2023, 9:00 pm
America’s car-mart, inc. schedules release of second quarter fiscal year 2024 results and conference call
ROGERS, Ark., Nov. 03, 2023 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announce...
November 3, 2023, 9:00 pm
Rosen, leading trial attorneys, encourages adapthealth corp. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ahco
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announce<...
November 3, 2023, 8:54 pm
Open society foundations announce 2023 soros justice fellows
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to announce the 20...
November 3, 2023, 8:52 pm
Clearstar announces appointment of mike pritts as chief executive officer
New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in the software and technology sectors. Alpharett...
November 3, 2023, 8:50 pm
Collective audience begins trading under new nasdaq ticker symbol, caud
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq:CAUD), a leading provider of digital consumer acquisition solutions, ...
November 3, 2023, 8:30 pm
Univest securities, llc announces closing of $10 million registered direct offering for its client gd culture group limited (nasdaq: gdc)
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank a...
November 3, 2023, 8:30 pm
Cornerstone funds announce continuing monthly distributions and reset distribution amounts for 2024
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone Total Retu...
November 3, 2023, 8:30 pm